140 related articles for article (PubMed ID: 7511960)
1. Prostacyclin (PGI) receptor binding and cyclic AMP synthesis activities of PGI1 analogues, SM-10906 and its methyl ester, SM-10902, in mastocytoma P-815 cells.
Oka M; Negishi M; Yamamoto T; Satoh K; Hirohashi T; Ichikawa A
Biol Pharm Bull; 1994 Jan; 17(1):74-7. PubMed ID: 7511960
[TBL] [Abstract][Full Text] [Related]
2. TEI-9063, a stable and highly specific prostacyclin analogue for the prostacyclin receptor in mastocytoma P-815 cells.
Negishi M; Hashimoto H; Yatsunami K; Kurozumi S; Ichikawa A
Prostaglandins; 1991 Sep; 42(3):225-37. PubMed ID: 1723528
[TBL] [Abstract][Full Text] [Related]
3. Differential regulation of thrombin- or ATP-induced mobilization of intracellular Ca2+ by prostacyclin receptor in mouse mastocytoma cells.
Negishi M; Hashimoto H; Ichikawa A
Biochem Biophys Res Commun; 1991 Apr; 176(1):102-7. PubMed ID: 1708239
[TBL] [Abstract][Full Text] [Related]
4. Characterization of prostaglandin and thromboxane receptors expressed on a megakaryoblastic leukemia cell line, MEG-01s.
Watanabe T; Yatomi Y; Sunaga S; Miki I; Ishii A; Nakao A; Higashihara M; Seyama Y; Ogura M; Saito H
Blood; 1991 Nov; 78(9):2328-36. PubMed ID: 1718495
[TBL] [Abstract][Full Text] [Related]
5. The use of stable prostaglandins to investigate prostacyclin (PGI2)-binding sites and PGI2-sensitive adenylate cyclase in human platelet membranes.
Lombroso M; Nicosia S; Paoletti R; Whittle BJ; Moncada S; Vane JR
Prostaglandins; 1984 Feb; 27(2):321-33. PubMed ID: 6326201
[TBL] [Abstract][Full Text] [Related]
6. Affinity for [3H]iloprost binding sites and cAMP synthesis activity of a 3-oxa-methano prostaglandin I1 analog, SM-10906, in human platelets and endothelial cells.
Hiroi T; Maruyama K; Hattori K; Ohnuki T; Nagatomo T; Watanabe K; Yamamoto T; Hara Y
Jpn J Pharmacol; 1997 May; 74(1):37-43. PubMed ID: 9195295
[TBL] [Abstract][Full Text] [Related]
7. Two types of prostacyclin receptor coupling to stimulation of adenylate cyclase and phosphatidylinositol hydrolysis in a cultured mast cell line, BNu-2cl3 cells.
Oka M; Negishi M; Nishigaki N; Ichikawa A
Cell Signal; 1993 Sep; 5(5):643-50. PubMed ID: 7508734
[TBL] [Abstract][Full Text] [Related]
8. Identification of a prostacyclin receptor coupled to the adenylate cyclase system via a stimulatory GTP-binding protein in mouse mastocytoma P-815 cells.
Hashimoto H; Negishi M; Ichikawa A
Prostaglandins; 1990 Nov; 40(5):491-505. PubMed ID: 1701557
[TBL] [Abstract][Full Text] [Related]
9. Functional and ligand binding studies suggest heterogeneity of platelet prostacyclin receptors.
Armstrong RA; Lawrence RA; Jones RL; Wilson NH; Collier A
Br J Pharmacol; 1989 Jul; 97(3):657-68. PubMed ID: 2474350
[TBL] [Abstract][Full Text] [Related]
10. Prostaglandin endoperoxide analogues which are both thromboxane receptor antagonists and prostacyclin mimetics.
Armstrong RA; Jones RL; MacDermot J; Wilson NH
Br J Pharmacol; 1986 Mar; 87(3):543-51. PubMed ID: 3026540
[TBL] [Abstract][Full Text] [Related]
11. Translocation of alpha subunits of stimulatory guanine nucleotide-binding proteins through stimulation of the prostacyclin receptor in mouse mastocytoma cells.
Negishi M; Hashimoto H; Ichikawa A
J Biol Chem; 1992 Feb; 267(4):2364-9. PubMed ID: 1370818
[TBL] [Abstract][Full Text] [Related]
12. Induction of prostacyclin receptor expression in human erythroleukemia cells.
Murray R; Furci L; FitzGerald GA
FEBS Lett; 1989 Sep; 255(1):172-4. PubMed ID: 2477277
[TBL] [Abstract][Full Text] [Related]
13. 7,7-Difluoroprostacyclin derivative, AFP-07, a highly selective and potent agonist for the prostacyclin receptor.
Chang CS; Negishi M; Nakano T; Morizawa Y; Matsumura Y; Ichikawa A
Prostaglandins; 1997 Feb; 53(2):83-90. PubMed ID: 9112287
[TBL] [Abstract][Full Text] [Related]
14. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
[TBL] [Abstract][Full Text] [Related]
15. Platelet receptor desensitization induced by elevated prostacyclin levels causes platelet-endothelial cell adhesion.
Darius H; Binz C; Veit K; Fisch A; Meyer J
J Am Coll Cardiol; 1995 Sep; 26(3):800-6. PubMed ID: 7543911
[TBL] [Abstract][Full Text] [Related]
16. Interrelationships between PGE1 and PGI2 binding and stimulation of adenylate cyclase.
Garrity MJ; Westcott KR; Eggerman TL; Andersen NH; Storm DR; Robertson RP
Am J Physiol; 1983 Apr; 244(4):E367-72. PubMed ID: 6132556
[TBL] [Abstract][Full Text] [Related]
17. Prostacyclin receptor-independent inhibition of phospholipase C activity by non-prostanoid prostacyclin mimetics.
Chow KB; Wong YH; Wise H
Br J Pharmacol; 2001 Dec; 134(7):1375-84. PubMed ID: 11724742
[TBL] [Abstract][Full Text] [Related]
18. Regulation of prostacyclin and prostaglandin E(2) receptor mediated responses in adult rat dorsal root ganglion cells, in vitro.
Rowlands DK; Kao C; Wise H
Br J Pharmacol; 2001 May; 133(1):13-22. PubMed ID: 11325789
[TBL] [Abstract][Full Text] [Related]
19. Effect of 7-fluoro prostacyclin, a stable prostacyclin analogue, on cAMP accumulation and prostaglandin binding in mastocytoma P-815 cells.
Mizuno Y; Ichikawa A; Tomita K
Prostaglandins; 1983 Nov; 26(5):785-95. PubMed ID: 6322238
[TBL] [Abstract][Full Text] [Related]
20. Desensitization of prostacyclin responsiveness in a neuronal hybrid cell line: selective loss of high affinity receptors.
Leigh PJ; MacDermot J
Br J Pharmacol; 1985 May; 85(1):237-47. PubMed ID: 2992650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
